RH Provider
Diana G Finkel, D.O.
Specialties:
Infectious Disease, Internal Medicine
Interests:
General Infectious Diseases, HIV/HCV, LGBQT
Languages Spoken
Russian
Aetna, Inc.
America's Choice Provider Network (ACPN)
AmeriHealth of NJ
Clover Health Plans
Devon Health Services/ULLICO
Horizon BCBS Managed Care
Horizon NJ Health
Horizon NJ Total Care (HNJH)
Horizon PPO Network
Medicaid
Medicare
Private Healthcare Systems
Prime Health Services, Inc.
Qual Care HMO
Qual Care PPO
Emblem Health
UHC Comm / Oxford
United Healthcare Community Plan (formerly AmeriChoice of NJ, Inc.)
WellCare Health Plans
Medicaid NJ
University Hospital, Newark
BS-Psychology and BA-Biology, Rutgers University (09/01/1989-05/31/1993)
D.O., University of Health Sciences College of Osteopathic Medicine (08/01/1993-05/25/1997)
Residency-Internal Medcine, Seton Hall Univerity School of Graduate Medical Education, Newark, NJ, USA (07/01/1997-06/30/2000)
Fellowship-Infectious Disease, Seton Hall Univerity School of Graduate Medical Education, Newark, NJ, USA (07/01/2000-06/30/2002)
General Infectious Diseases, HIV/HCV, LGBQT
Locations
40.740542657877, -74.19226466709
140 Bergen Street
Newark, NJ 07103
United States
P:
973-972-9000
Provider Biography
Dr. Finkel is an Associate Professor in the Department of Medicine and Director of the Infectious
Disease Fellowship Program at Rutgers New Jersey Medical School. She received her Doctor of
Osteopathic Medicine from the Kansas City University of Medicine and Biosciences-College
Osteopathic Medicine and completed her Internal Medicine Residency and Infectious Disease
Fellowship at Seton Hall University/ St. Michaels Medical Center in Newark, New Jersey.
Dr. Finkel has been a Faculty member at the New Jersey Medical School since 2018. She has been a
community provider for over 18 years and has been actively involved in patient care, medical
education and clinical research. She is passionately committed to improving health disparities in
marginalized populations and has coordinated community care for diverse populations at risk,
including immigration detainees, LGBQT marginally housed youth and persons who use drugs. She
has served as a Principal and co-investigator in the Rutgers NIH sponsored HIV Clinical Trials Unit in
both treatment and prevention trials. Her clinical and research interests include HIV infection,
transgender community health, telemedicine and the intersection of addiction and infectious diseases.